Ahalya Ratnavel, Francesca R Dino, Celina Jiang, Sarah Azmy, Kathryn A Wyman-Chick, Ece Bayram
{"title":"Risk factors and predictors for Lewy body dementia: a systematic review.","authors":"Ahalya Ratnavel, Francesca R Dino, Celina Jiang, Sarah Azmy, Kathryn A Wyman-Chick, Ece Bayram","doi":"10.1038/s44400-025-00022-2","DOIUrl":null,"url":null,"abstract":"<p><p>Lewy body dementia (LBD), including Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), is a common and burdensome dementia. Determining risk factors and predictors can provide insights into pathogenesis and guide treatment efforts. In this systematic review, we searched PubMed, Embase, and Web of Science for longitudinal studies assessing risk/prodromal factors; including participants without dementia at baseline; with LBD as the outcome; with good/high quality based on the Newcastle-Ottawa Quality Assessment Scale. Across 167 included studies, more consistently reported factors were older age, male sex, <i>APOEe4</i>, <i>GBA</i>, changes in cognition, mood, behavior, sleep, gait/posture, speech, parkinsonism, smell loss, autonomic dysfunction, white matter disease on MRI, lower CSF amyloid β42 and higher CSF/blood neurofilament light chain. The majority focused on clinical factors preceding PDD with cohorts from North America and Europe, limiting generalizability. Further efforts with more representative cohorts are needed to better identify people at risk for LBD.</p>","PeriodicalId":520469,"journal":{"name":"NPJ dementia","volume":"1 1","pages":"20"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321581/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ dementia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s44400-025-00022-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lewy body dementia (LBD), including Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), is a common and burdensome dementia. Determining risk factors and predictors can provide insights into pathogenesis and guide treatment efforts. In this systematic review, we searched PubMed, Embase, and Web of Science for longitudinal studies assessing risk/prodromal factors; including participants without dementia at baseline; with LBD as the outcome; with good/high quality based on the Newcastle-Ottawa Quality Assessment Scale. Across 167 included studies, more consistently reported factors were older age, male sex, APOEe4, GBA, changes in cognition, mood, behavior, sleep, gait/posture, speech, parkinsonism, smell loss, autonomic dysfunction, white matter disease on MRI, lower CSF amyloid β42 and higher CSF/blood neurofilament light chain. The majority focused on clinical factors preceding PDD with cohorts from North America and Europe, limiting generalizability. Further efforts with more representative cohorts are needed to better identify people at risk for LBD.
路易体痴呆(LBD)包括帕金森病痴呆(PDD)和伴路易体痴呆(DLB),是一种常见且负担沉重的痴呆。确定危险因素和预测因素可以深入了解发病机制并指导治疗工作。在这篇系统综述中,我们检索了PubMed、Embase和Web of Science,寻找评估风险/前驱因素的纵向研究;包括基线时没有痴呆的参与者;以LBD为结果;根据纽卡斯尔-渥太华质量评估量表,具有良好/高质量。在167项纳入的研究中,更一致报道的因素是年龄较大、男性、APOEe4、GBA、认知、情绪、行为、睡眠、步态/姿势、语言、帕金森病、嗅觉丧失、自主神经功能障碍、MRI上的白质疾病、脑脊液淀粉样蛋白β42降低和脑脊液/血液神经丝轻链升高。大多数研究集中在PDD之前的临床因素,来自北美和欧洲的队列,限制了普遍性。为了更好地识别有LBD风险的人群,需要进一步努力,建立更具代表性的队列。